A CLINICAL OVERVIEW OF TREATMENT DECISIONS IN THE MANAGEMENT OF SPASTICITY

Citation
Me. Gormley et al., A CLINICAL OVERVIEW OF TREATMENT DECISIONS IN THE MANAGEMENT OF SPASTICITY, Muscle & nerve, 1997, pp. 14-20
Citations number
14
Categorie Soggetti
Neurosciences
Journal title
ISSN journal
0148639X
Year of publication
1997
Supplement
6
Pages
14 - 20
Database
ISI
SICI code
0148-639X(1997):<14:ACOOTD>2.0.ZU;2-9
Abstract
Spasticity from an upper motor neuron syndrome may cause a variety of symptoms that interfere with function. Decisions regarding spasticity treatment are influenced by the chronicity, severity and distribution of the spasticity: the locus of injury; the presence and severity of c o-morbidities; the availability of support; and the goals of treatment . Not all spasticity can or even should be treated; tone reduction is indicated only if spasticity interferes with some level of function. p ositioning, care, or comfort. Treatment goals should be well outlined before treatment begins. Botulinum toxin may be used to treat focal sp asticity as part of an overall treatment plan. (C) 1997 John Wiley & S ons, Inc.